Circulating sphingomyelins and mortality in a community-based Korean cohort: the Korean Genome and epidemiology study.
- 1Department of Laboratory Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
- 2Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.
- 3Department of Laboratory Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. [email protected].
Abstract
Background
Circulating sphingomyelins (SMs) have been proposed as biomarkers of mortality and cardiovascular risk, but findings have varied across populations. We aimed to evaluate the associations in a community-based Korean cohort.Methods
This cohort study included 2,434 participants from the Ansan-Ansung cohort of the Korean Genome and Epidemiology Study. Seven SM species were measured at the 2005-2006 examination, and mortality data were linked through December 2024. Associations with all-cause, cardiovascular, and non-cardiovascular mortality and the composite cardiovascular outcome were examined using Cox proportional hazards models adjusted for demographic, lifestyle, clinical and laboratory factors. Multiple testing was addressed using the Benjamini-Hochberg procedure across 28 tests within each adjustment model.Results
During a median follow-up of 18.5 years, 426 deaths occurred, including 79 cardiovascular deaths. In the fully adjusted model, higher SM 16:0 levels were nominally associated with all-cause mortality (hazard ratio 1.70; 95% CI, 1.07-2.70; P = 0.025), but the association was not statistically significant after correction for multiple testing. None of the seven SM species were significantly associated with all-cause, cardiovascular, or non-cardiovascular mortality or with the composite cardiovascular outcome after correction for multiple testing.Conclusions
In this community-based Korean cohort, circulating SMs were not significantly associated with mortality or cardiovascular outcomes. This suggests that the prognostic relevance of circulating SMs may be limited and may vary according to population characteristics.
Related
- Associations of Self-Reported Physical Activity with Gut Microbial Diversity and Community Structure in Young, Apparently Healthy Korean Men.
- Specialty-aware benchmark design, split integrity, and baseline evaluation for Korean medical question answering
- A Drug-Referenced Machine-Learning Framework for Prioritizing Korean Herbal Formulations in Hypertension Using Linear SVM and Graph Convolutional Networks
- Towards a holistic epidemiology of Streptococcus agalactiae using the BakRep repository
- Fungi in Asthma: From Epidemiology and Airway Mycobiome to Molecular Mechanisms and Novel Allergenic Phytopathogens
BibTeX
@article{kwon2026circulating,
title = {{Circulating sphingomyelins and mortality in a community-based Korean cohort: the Korean Genome and epidemiology study.}},
author = {Soon Sung Kwon and John Hoon Rim and Yonggeun Cho and Jikyo Lee and Kwang Seob Lee and Sang-Guk Lee and Jong-Baeck Lim},
journal = {Lipids in health and disease},
year = {2026},
month = oct,
doi = {10.1186/s12944-026-03091-1},
url = {https://europepmc.org/article/MED/42958537},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Circulating sphingomyelins and mortality in a community-based Korean cohort: the Korean Genome and epidemiology study.
AU - Soon Sung Kwon
AU - John Hoon Rim
AU - Yonggeun Cho
AU - Jikyo Lee
AU - Kwang Seob Lee
AU - Sang-Guk Lee
AU - Jong-Baeck Lim
PY - 2026
DA - 2026/10/13
JO - Lipids in health and disease
DO - 10.1186/s12944-026-03091-1
UR - https://europepmc.org/article/MED/42958537
AB - Background Circulating sphingomyelins (SMs) have been proposed as biomarkers of mortality and cardiovascular risk, but findings have varied across populations. We aimed to evaluate the associations in a community-based Korean cohort.Methods This cohort study included 2,434 participants from the Ansan-Ansung cohort of the Korean Genome and Epidemiology Study. Seven SM species were measured at the 2005-2006 examination, and mortality data were linked through December 2024. Associations with all-cause, cardiovascular, and non-cardiovascular mortality and the composite cardiovascular outcome were examined using Cox proportional hazards models adjusted for demographic, lifestyle, clinical and laboratory factors. Multiple testing was addressed using the Benjamini-Hochberg procedure across 28 tests within each adjustment model.Results During a median follow-up of 18.5 years, 426 deaths occurred, including 79 cardiovascular deaths. In the fully adjusted model, higher SM 16:0 levels were nominally associated with all-cause mortality (hazard ratio 1.70; 95% CI, 1.07-2.70; P = 0.025), but the association was not statistically significant after correction for multiple testing. None of the seven SM species were significantly associated with all-cause, cardiovascular, or non-cardiovascular mortality or with the composite cardiovascular outcome after correction for multiple testing.Conclusions In this community-based Korean cohort, circulating SMs were not significantly associated with mortality or cardiovascular outcomes. This suggests that the prognostic relevance of circulating SMs may be limited and may vary according to population characteristics.
SN - 1476-511X
ER -